Patent details

Basic Information

Publication number:

EP3458085

PCT Application Number:

EP2017059976

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177247608

PCT Publication Number:

WO2017198435

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GLYCOSYLATED VWF FUSION PROTEINS WITH IMPROVED PHARMACOKINETICS

French Title of Invention:

PROTÉINES DE FUSION VWF GLYCOSYLÉES À PHARMACOCINÉTIQUE AMÉLIORÉE

German Title of Invention:

GLYKOSYLIERTE VWF-FUSIONSPROTEINE MIT VERBESSERTER PHARMAKOKINETIK

SPC Number:

Dates

Filing date:

26/04/2017

Grant date:

07/12/2022

EP Publication Date:

27/03/2019

PCT Publication Date:

23/11/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/12/2022

EP B1 Publication Date:

07/12/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/04/2023

Expiration date:

26/04/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/11/2022

 

 

Name:

Octapharma AG

Address:

Seidenstrasse 2, 8853 Lachen, Switzerland (CH)

Inventor

1

Name:

KANNICHT, Christoph

Address:

Germany (DE)

2

Name:

SCHWIENTEK, Tilo

Address:

Germany (DE)

3

Name:

WINGE, Stefan

Address:

Sweden (SE)

4

Name:

SOLECKA-WITULSKA, Barbara

Address:

Germany (DE)

Priority

Priority Number:

16170690

Priority Date:

20/05/2016

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 38/36;

Publication

European Patent Bulletin

Issue number:

202249

Publication date:

07/12/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages